Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

2.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

3.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

4.

Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

5.

The New Canadian Guidelines for Drinking at High Risk, AUD.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot